Novartis Investigative Site

Chikushino-shi, Fukuka 818-8516

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Heart Failure With Preserved Ejection Fraction, Resistant Hypertension

Studies at this site

• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients. — Completed
• Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction — Completed